FV Hospital launches AI-enabled myopia control service

FV Hospital, one of the largest private hospitals in Vietnam, has recently introduced a myopia control programme for children and adolescents aged 3-18. 

The new service aims to screen young people for myopia risks, predict future myopia levels, and provide a plan to control the progression of myopia. It is offered annually and includes screening, treatment plans, and guidance on myopia control, including lifestyle changes and quarterly regular follow-ups. 

At the core of the programme is Myopia Master by Australian company Myopia Profile. The device uses AI to predict and analyse the progression of myo​​pia. FV eye doctors use its analysis to tailor myopia control protocols for their patients. 

Besides Myopia Master, the programme is also underpinned by the Pentacam refractive measurement system, which evaluates corneal curvature, thickness, and condition and detects congenital corneal diseases.  

Sunway Medical Centre adopts AI for radiology

Malaysia's largest private quaternary hospital, Sunway Medical Centre in Sunway City, has recently adopted a radiology AI solution from Australia. 

Annalise.ai's Enterprise Chest X-ray (CXR) has been integrated into the hospital's medical imaging workflow, a press release noted. The technology, according to Annalise.ai, can identify up to 124 findings on CXRs within seconds. 

SMC CEO Dr Seow Vei Ken said the AI solution will support its clinicians in the rapid triaging of cases and prioritising patients based on urgency.

Xiaomi backs breast cancer screening initiative in India

Consumer electronics giant Xiaomi is supporting a breast cancer screening initiative by world-famous cricketer Yuvraj Singh in India. 

Singh's non-profit foundation, YouWeCan, is running the Swasth Mahila Swasth Bharat project, which targets to screen 150,000 women for breast cancer across 15 Indian states within a year. It also aims to raise awareness of breast cancer risk and self-assessment, as well as ensure early detection and delivery of timely treatment. 

Without giving into much detail, Xiaomi said it will render its technological expertise in delivering community-based screening to large communities.